{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:18:41Z","timestamp":1793409521251,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic Arizona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.cgh.2021.04.013","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T23:35:42Z","timestamp":1618961742000},"page":"e508-e528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Germline Cancer Susceptibility Gene Testing in Unselected Patients With Colorectal Adenocarcinoma: A Multicenter Prospective Study"],"prefix":"10.1016","volume":"20","author":[{"suffix":"Jr.","given":"Pedro L.S.","family":"Uson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Riegert-Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Boardman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kisiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Mountjoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neej","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Lizaola-Mayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitesh J.","family":"Borad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad B.","family":"Sonbol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Leighton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suryakanth","family":"Gurudu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harminder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Klint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie L.","family":"Kunze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Golafshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed D.","family":"Esplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Nussbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Keith","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanio S.","family":"Bekaii-Saab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloy","family":"Jewel Samadder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2021.04.013_bib1","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.mayocp.2019.01.042","article-title":"Hereditary cancer syndromes-a primer on diagnosis and management, part 2: gastrointestinal cancer syndromes","volume":"94","author":"Samadder","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cgh.2021.04.013_bib2","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability\u2013high advanced colorectal cancer","volume":"383","author":"Andr\u00e9","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2021.04.013_bib3","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1200\/JCO.2016.71.0012","article-title":"Cancer susceptibility gene mutations in individuals with colorectal cancer","volume":"35","author":"Yurgelun","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cgh.2021.04.013_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12885-015-1224-y","article-title":"Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk","volume":"15","author":"Judkins","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cgh.2021.04.013_bib5","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.15_suppl.1577","article-title":"Prevalence of germline genetic alterations in colorectal cancer patients","volume":"36","author":"Cercek","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cgh.2021.04.013_bib6","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/S0016-5085(03)00376-7","article-title":"Genetic testing for high-risk colon cancer patients","volume":"124","author":"Grady","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.04.013_bib7","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/(SICI)1097-0142(19960915)78:6<1149::AID-CNCR1>3.0.CO;2-5","article-title":"Hereditary nonpolyposis colorectal cancer (Lynch syndrome): an updated review","volume":"78","author":"Lynch","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.cgh.2021.04.013_bib8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1706450","article-title":"Olaparib for metastatic breast cancer in patients with a germline BRCA mutation","volume":"377","author":"Robson","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2021.04.013_bib9","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S1470-2045(17)30469-2","article-title":"Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1\/2 mutation (SOLO2\/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial","volume":"18","author":"Pujade-Lauraine","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cgh.2021.04.013_bib10","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1911440","article-title":"Olaparib for metastatic castration-resistant prostate cancer","volume":"382","author":"de Bono","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2021.04.013_bib11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1903387","article-title":"Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer","volume":"381","author":"Golan","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2021.04.013_bib12","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jama.2017.11137","article-title":"Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing","volume":"318","author":"Mandelker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2021.04.013_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0021-5198(19)43255-1","article-title":"Constrictor responses of isolated and perfused monkey coronary arteries to pindolol","volume":"47","author":"Nakane","year":"1988","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.cgh.2021.04.013_bib14","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1200\/JCO.2013.53.6607","article-title":"Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment","volume":"32","author":"Kurian","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cgh.2021.04.013_bib15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1200\/JCO.18.01631","article-title":"Underdiagnosis of hereditary breast cancer: are genetic testing guidelines a tool or an obstacle?","volume":"37","author":"Beitsch","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cgh.2021.04.013_bib16","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.6004\/jnccn.2019.0044","article-title":"NCCN guidelines insights: genetic\/familial high-risk assessment: colorectal, version 2.2019","volume":"17","author":"Gupta","year":"2019","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.cgh.2021.04.013_bib17","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/j.gastro.2017.11.004","article-title":"Germline genetic features of young individuals with colorectal cancer","volume":"154","author":"Stoffel","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.04.013_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41525-019-0096-5","article-title":"Impact of free cancer predisposition cascade genetic testing on uptake in Singapore","volume":"4","author":"Courtney","year":"2019","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.cgh.2021.04.013_bib19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ygyno.2019.11.005","article-title":"Low rates of cascade genetic testing among families with hereditary gynecologic cancer: an opportunity to improve cancer prevention","volume":"156","author":"Griffin","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cgh.2021.04.013_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cgh.2007.12.014","article-title":"Sharing genetic test results in Lynch syndrome: communication with close and distant relatives","volume":"6","author":"Stoffel","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.04.013_bib21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/jnci\/djy147","article-title":"Cascade genetic testing of relatives for hereditary cancer risk: results of an online initiative","volume":"111","author":"Caswell-Jin","year":"2019","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cgh.2021.04.013_bib22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/jjco\/hyw178","article-title":"Prevalence of Lynch syndrome and Lynch-like syndrome among patients with colorectal cancer in a Japanese hospital-based population","volume":"47","author":"Chika","year":"2017","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.cgh.2021.04.013_bib23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gutjnl-2011-300041","article-title":"Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer","volume":"61","author":"P\u00e9rez-Carbonell","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2021.04.013_bib24","first-page":"1","article-title":"Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer","volume":"9","author":"Lin","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.cgh.2021.04.013_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-39525-3","article-title":"Prognostic impact of ATM mutations in patients with metastatic colorectal cancer","volume":"9","author":"Randon","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.cgh.2021.04.013_bib26","doi-asserted-by":"crossref","first-page":"10680","DOI":"10.3748\/wjg.v22.i48.10680","article-title":"Efficiency of olaparib in colorectal cancer patients with an alteration of the homologous repair protein","volume":"22","author":"Ghiringhelli","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.04.013_bib27","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1158\/1078-0432.CCR-19-2409","article-title":"A\u00a0subset of colorectal cancers with cross-sensitivity to olaparib and oxaliplatin","volume":"26","author":"Arena","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cgh.2021.04.013_bib28","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.2147\/OTT.S89154","article-title":"Combined olaparib and oxaliplatin inhibits tumor proliferation and induces G2\/M arrest and \u03b3-H2AX foci formation in colorectal cancer","volume":"8","author":"Xu","year":"2015","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.cgh.2021.04.013_bib29","article-title":"Pathologic complete response in patient with ATM mutation after neoadjuvant FOLFOXIRI plus panitumumab therapy for locally advanced colon cancer: a case report","author":"McGillivray","year":"2020","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.cgh.2021.04.013_bib30","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/jamaoncol.2020.6252","article-title":"Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome","volume":"7","author":"Samadder","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.cgh.2021.04.013_bib31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1200\/JCO.18.01631","article-title":"Underdiagnosis of hereditary breast cancer: are genetic testing guidelines a tool or an obstacle?","volume":"37","author":"Beitsch","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cgh.2021.04.013_bib32","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jmoldx.2015.04.009","article-title":"A\u00a0systematic comparison of traditional and multigene panel testing for hereditary breast and ovarian cancer genes in more than 1000 patients","volume":"17","author":"Lincoln","year":"2015","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.cgh.2021.04.013_bib33","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41436-018-0033-5","article-title":"Prevalence and properties of intragenic copy-number variation in Mendelian disease genes","volume":"21","author":"Truty","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.cgh.2021.04.013_bib34","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1471-2164-12-184","article-title":"Accurate and exact CNV identification from targeted high-throughput sequence data","volume":"12","author":"Nord","year":"2011","journal-title":"BMC Genomics"},{"key":"10.1016\/j.cgh.2021.04.013_bib35","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1200\/JCO.2013.53.6607","article-title":"Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment","volume":"32","author":"Kurian","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cgh.2021.04.013_bib36","first-page":"1449","article-title":"Large genomic deletions and duplications in the BRCA1 gene identified by\u00a0a novel quantitative method","volume":"63","author":"Hogervorst","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.cgh.2021.04.013_bib37","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/gim.2017.37","article-title":"Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria","volume":"19","author":"Nykamp","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.cgh.2021.04.013_bib38","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cgh.2021.04.013_bib39","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1200\/JCO.2010.34.0778","article-title":"Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer","volume":"29","author":"Cybulski","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cgh.2021.04.013_bib40","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/tbj.13969","article-title":"Risk for breast cancer and management of unaffected individuals with non-BRCA hereditary breast cancer","volume":"26","author":"Wood","year":"2020","journal-title":"Breast J"},{"key":"10.1016\/j.cgh.2021.04.013_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059709","article-title":"Spectrum and risk of neoplasia in Werner syndrome: a systematic review","volume":"8","author":"Lauper","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2021.04.013_bib42","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/ijc.29876","article-title":"The APC I1307K allele conveys a significant increased risk for cancer","volume":"138","author":"Leshno","year":"2016","journal-title":"Int J Cancer"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235652100447X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235652100447X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:39:01Z","timestamp":1761543541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154235652100447X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S154235652100447X"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2021.04.013","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Germline Cancer Susceptibility Gene Testing in Unselected Patients With Colorectal Adenocarcinoma: A Multicenter Prospective Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2021.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}